サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1429905

ファーマコビジランスの世界市場レポート 2024年

Pharmacovigilance Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ファーマコビジランスの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

ファーマコビジランスの市場規模は、今後数年間で急速に成長すると予想されています。 2028年には12.9%の年間複合成長率（CAGR）で141億1,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、医療費の増加、政府支援の増加、人口の高齢化などの要因に起因すると考えられます。予測期間中に予想される主要動向には、投資の増加、人工知能の使用、革新的なプラットフォームの採用、革新的なクラウドベースのシステムの利用、戦略的な合併と買収が含まれます。

ファーマコビジランス市場は、製薬分野における研究開発（R&D）活動の増加により成長すると予想されています。研究開発への投資により、製薬会社は安全性プロファイルが向上した新薬を開発できるようになります。医薬品開発中の厳格な前臨床試験と臨床試験は、潜在的な安全性の懸念を早期に特定するのに役立ち、リスク軽減戦略をタイムリーに実行できるようになります。さらに、研究開発の取り組みは、有害事象のモニタリング、データ分析、シグナル検出の技術の進歩に貢献し、市販後の副作用の早期発見を促進します。 2022年2月にIQVIAが行った調査では、米国におけるベンチャーキャピタルの取引活動と投資が大幅に増加しており、製薬大手は2021年に研究開発に過去最高となる1,330億米ドルを投資し、前年比44％増となっていることが明らかになりました。この研究開発活動の急増がファーマコビジランス市場の成長を支えています。

ファーマコビジランス市場は、医療費の増加により成長が見込まれています。資金の増加により、医療システムは、薬物副作用の効率的な特定と評価を行うための高度な技術、データ分析、専門家チームに投資できるようになります。また、医療支出の増加により、ファーマコビジランスの実践に関する医療専門家のトレーニングと教育が強化され、潜在的な薬物関連の問題のタイムリーな報告と分析が保証されます。Centers for Medicare & Medicaid Servicesは、国民医療支出が増加し、2031年までにGDPの19.6%に達すると予測しています。さらに、全米慢性疾患責任者協会は、成人アメリカ人のほぼ60%が少なくとも1つの慢性疾患を患っていると報告し、その必要性を強調しています。医療費の増加に向けて。この医療支出の増加傾向は、ファーマコビジランス市場を牽引すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界のファーマコビジランス市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界のファーマコビジランスの市場規模実績と成長、2018～2023年
  • 世界のファーマコビジランス市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界のファーマコビジランス市場、タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 自発的報告
  • ADR報告の強化
  • 対象を絞った自発的報告
  • コホートイベントのモニタリング
  • EHR鉱業
  • 世界のファーマコビジランス市場、サービスプロバイダー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 社内
  • 請負業務委託
  • 世界のファーマコビジランス市場、プロセスフロー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 症例データ管理
  • 信号検出
  • リスク管理体制
  • 世界のファーマコビジランス市場、臨床試験フェーズ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 前臨床
  • フェーズI
  • フェーズII
  • フェーズIII
  • フェーズIV
  • 世界のファーマコビジランス市場、エンドユーザー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 病院
  • 製薬会社
  • その他

第7章 地域と国の分析

  • 世界のファーマコビジランス市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
  • 世界のファーマコビジランス市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ファーマコビジランス市場の競合情勢
  • ファーマコビジランス市場の企業プロファイル
    • IQVIA
    • Cognizant
    • ICON Plc
    • Accenture plc
    • PAREXEL International Corporation.

第31章 その他の大手と革新的な企業

  • United BioSource LLC
  • ArisGlobal
  • Quanticate
  • Wipro Limited
  • Linical Americas
  • Novotech CRO
  • Wuxi Apptec
  • Simcere Pharmaceutical Group
  • Lee's Pharmaceutical Holdings
  • Luye Pharma Group
  • EXTEDO
  • Arriello
  • PrimeVigilance
  • Axios International
  • C3i Solutions

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

目次
Product Code: r14876

Pharmacovigilance encompasses the science and practices dedicated to identifying, evaluating, understanding, and mitigating side effects and other medical/vaccination-related issues. Its purpose is to assess whether the benefits of a drug outweigh its risks, and this scrutiny persists even after drug approval.

The primary types of pharmacovigilance include spontaneous reporting, intensified adverse drug reaction (ADR) reporting, targeted spontaneous reporting, cohort event monitoring, and electronic health record (EHR) mining. Spontaneous reporting relies on individuals' voluntary reporting of suspected adverse drug reactions to local or national pharmacovigilance centers, representing a passive approach. Process flows involve case data management, signal detection, and risk management systems. Service providers can be in-house or contracted for outsourcing, covering various clinical trial phases such as preclinical, phase I, phase II, phase III, and phase IV. These services cater to different end-users, including hospitals, pharmaceutical companies, and others.

The pharmacovigilance market research report is one of a series of new reports from The Business Research Company that provides pharmacovigilance market statistics, including pharmacovigilance industry global market size, regional shares, competitors with a pharmacovigilance market share, detailed pharmacovigilance market segments, market trends, and opportunities, and any further data you may need to thrive in the pharmacovigilance industry. This pharmacovigilance market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmacovigilance market size has grown rapidly in recent years. It will grow from $7.63 billion in 2023 to $8.67 billion in 2024 at a compound annual growth rate (CAGR) of 13.6%. The expansion observed in the historical period can be attributed to the increasing incidence of adverse drug reactions (ADRs), rising research and development (R&D) activities, growing rates of drug development, an increased focus on personalized medicine, and the rising prevalence of chronic diseases.

The pharmacovigilance market size is expected to see rapid growth in the next few years. It will grow to $14.11 billion in 2028 at a compound annual growth rate (CAGR) of 12.9%. The anticipated growth in the forecast period can be attributed to factors such as the rising healthcare expenditure, increasing government support, and the aging population. Key trends expected in the forecast period include increasing investments, the use of artificial intelligence, adoption of innovative platforms, utilization of innovative cloud-based systems, and strategic mergers and acquisitions.

The pharmacovigilance market is set to experience growth due to increasing research and development (R&D) activities in the pharmaceutical sector. Investments in R&D enable pharmaceutical companies to develop new drugs with improved safety profiles. Rigorous preclinical and clinical testing during drug development aids in early identification of potential safety concerns, allowing for timely implementation of risk mitigation strategies. Additionally, R&D efforts contribute to the advancement of technologies for adverse event monitoring, data analysis, and signal detection, facilitating early detection of adverse drug reactions post-marketing. A study by IQVIA in February 2022 revealed a significant increase in venture capital deal activity and investments in the U.S., with pharmaceutical giants investing a record $133 billion in R&D in 2021, marking a 44% increase over previous years. This surge in R&D activities supports the growth of the pharmacovigilance market.

The pharmacovigilance market is expected to witness growth propelled by rising healthcare expenditure. Increased funding enables healthcare systems to invest in advanced technologies, data analytics, and expert teams for efficient identification and assessment of adverse drug reactions. Higher healthcare spending also facilitates better training and education of healthcare professionals on pharmacovigilance practices, ensuring timely reporting and analysis of potential drug-related issues. The Centers for Medicare & Medicaid Services projects an increase in National Health Expenditures, reaching 19.6% of GDP by 2031. Additionally, the National Association of Chronic Disease Directors reported that almost 60% of adult Americans have at least one chronic disease, emphasizing the need for increased healthcare expenditure. This upward trajectory in healthcare spending is expected to drive the pharmacovigilance market.

Pharmacovigilance market players are strategically adopting artificial intelligence (AI) to enhance efficiency. AI contributes to improved accuracy and efficiency in pharmacovigilance activities, leading to better patient outcomes. Pharma companies utilizing AI can streamline processes, enhance data management, and expedite drug discovery while reducing costs and enhancing safety. For instance, Deloitte and Sanofi collaborated on an AI software-as-a-service adverse events case intake platform called ConvergeHEALTH Safety to modernize pharmacovigilance. Sanofi reported increased case quality and processing efficiency within pharmacovigilance through the automation of case intake. The integration of AI is a significant focus in the pharmacovigilance market.

Pharmacovigilance providers are making substantial investments to expand their product portfolios and geographic presence. In September 2022, the PharmaLex Group opened a new branch in Beijing, China, offering comprehensive pharmacovigilance, regulatory affairs, development advice, and quality management services to global companies entering the Chinese market. The PharmaLex Group's expansion aims to provide enhanced support and value across the product lifecycle.

In January 2023, AmerisourceBergen acquired Pharma Lex to augment its existing service offering and provide pharmaceutical and biotech companies with comprehensive support for pharmacovigilance systems and operations, including benefit-risk management services. These strategic investments contribute to the growth and expansion of the pharmacovigilance market.

Major companies operating in the pharmacovigilance market report are IQVIA, Cognizant, ICON PLC, Accenture PLC, PAREXEL International Corporation., United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, Wuxi Apptec, Simcere Pharmaceutical Group, Lee's Pharmaceutical Holdings, Luye Pharma Group, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Alcon, Secure AI Labs, OmniSol dot Tech, Canna Call Company, Veripad, Prevnos Inc., Lifescient, Inc., BeiGene, QuintilesIMS, Labcorp Drug Development, Pharmaceutical Product Development Inc., PRA Health Sciences, Synowledge LLC, RAPAhub, illuminate health, Invenio Medical, ClinChoice Inc., MSD, Novasyte, Fortrea Holdings Inc., Syneos Health Clinical, Zoetis Inc., Telerx Marketing Inc., Gilead Sciences, Inc., Elanco, Abbott Laboratories, Spimaco, Teva Pharmaceutical Industries Ltd., DSV Healthcare

North America was the largest region in the pharmacovigilance market in 2023. Asia-Pacific is expected to be the fastest growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmacovigilance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The pharmacovigilance market includes revenues earned by collecting, analyzing, monitoring, and preventing adverse effects in drugs and therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmacovigilance Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmacovigilance market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmacovigilance? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmacovigilance market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Spontaneous Reporting; Intensified ADR Reporting; Targeted Spontaneous Reporting; Cohort Event Monitoring; EHR Mining
  • 2) By Service Provider: In-House; Contract Outsourcing
  • 3) By Process Flow: Case Data Management; Signal Detection; Risk Management System
  • 4) By Clinical Trial Phases: Preclinical; Phase I; Phase II; Phase III; Phase IV
  • 5) By End User: Hospitals; Pharmaceutical Companies; Other End Users
  • Companies Mentioned: IQVIA; Cognizant; ICON Plc; Accenture plc; PAREXEL International Corporation.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmacovigilance Market Characteristics

3. Pharmacovigilance Market Trends And Strategies

4. Pharmacovigilance Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Pharmacovigilance Market Size and Growth

  • 5.1. Global Pharmacovigilance Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Pharmacovigilance Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Pharmacovigilance Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pharmacovigilance Market Segmentation

  • 6.1. Global Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Spontaneous Reporting
  • Intensified ADR Reporting
  • Targeted Spontaneous Reporting
  • Cohort Event Monitoring
  • EHR Mining
  • 6.2. Global Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • In-House
  • Contract Outsourcing
  • 6.3. Global Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Case Data Management
  • Signal Detection
  • Risk Management System
  • 6.4. Global Pharmacovigilance Market, Segmentation By Clinical Trial Phases, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Preclinical
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • 6.5. Global Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Pharmaceutical Companies
  • Other End Users

7. Pharmacovigilance Market Regional And Country Analysis

  • 7.1. Global Pharmacovigilance Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Pharmacovigilance Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pharmacovigilance Market

  • 8.1. Asia-Pacific Pharmacovigilance Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pharmacovigilance Market

  • 9.1. China Pharmacovigilance Market Overview
  • 9.2. China Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pharmacovigilance Market

  • 10.1. India Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pharmacovigilance Market

  • 11.1. Japan Pharmacovigilance Market Overview
  • 11.2. Japan Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pharmacovigilance Market

  • 12.1. Australia Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pharmacovigilance Market

  • 13.1. Indonesia Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pharmacovigilance Market

  • 14.1. South Korea Pharmacovigilance Market Overview
  • 14.2. South Korea Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pharmacovigilance Market

  • 15.1. Western Europe Pharmacovigilance Market Overview
  • 15.2. Western Europe Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pharmacovigilance Market

  • 16.1. UK Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pharmacovigilance Market

  • 17.1. Germany Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pharmacovigilance Market

  • 18.1. France Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pharmacovigilance Market

  • 19.1. Italy Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pharmacovigilance Market

  • 20.1. Spain Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pharmacovigilance Market

  • 21.1. Eastern Europe Pharmacovigilance Market Overview
  • 21.2. Eastern Europe Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pharmacovigilance Market

  • 22.1. Russia Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pharmacovigilance Market

  • 23.1. North America Pharmacovigilance Market Overview
  • 23.2. North America Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pharmacovigilance Market

  • 24.1. USA Pharmacovigilance Market Overview
  • 24.2. USA Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pharmacovigilance Market

  • 25.1. Canada Pharmacovigilance Market Overview
  • 25.2. Canada Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pharmacovigilance Market

  • 26.1. South America Pharmacovigilance Market Overview
  • 26.2. South America Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pharmacovigilance Market

  • 27.1. Brazil Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pharmacovigilance Market

  • 28.1. Middle East Pharmacovigilance Market Overview
  • 28.2. Middle East Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pharmacovigilance Market

  • 29.1. Africa Pharmacovigilance Market Overview
  • 29.2. Africa Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pharmacovigilance Market Competitive Landscape And Company Profiles

  • 30.1. Pharmacovigilance Market Competitive Landscape
  • 30.2. Pharmacovigilance Market Company Profiles
    • 30.2.1. IQVIA
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Cognizant
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. ICON Plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Accenture plc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. PAREXEL International Corporation.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Pharmacovigilance Market Other Major And Innovative Companies

  • 31.1. United BioSource LLC
  • 31.2. ArisGlobal
  • 31.3. Quanticate
  • 31.4. Wipro Limited
  • 31.5. Linical Americas
  • 31.6. Novotech CRO
  • 31.7. Wuxi Apptec
  • 31.8. Simcere Pharmaceutical Group
  • 31.9. Lee's Pharmaceutical Holdings
  • 31.10. Luye Pharma Group
  • 31.11. EXTEDO
  • 31.12. Arriello
  • 31.13. PrimeVigilance
  • 31.14. Axios International
  • 31.15. C3i Solutions

32. Global Pharmacovigilance Market Competitive Benchmarking

33. Global Pharmacovigilance Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pharmacovigilance Market

35. Pharmacovigilance Market Future Outlook and Potential Analysis

  • 35.1 Pharmacovigilance Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Pharmacovigilance Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Pharmacovigilance Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer